Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF with chemotherapy in advanced colorectal cancer
NCT00257322Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Apr 2003
- Primary completion
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in colorectal cancer (CRC), sponsored by University of California, Irvine. Started Apr 2003; status: completed.
02
Drugs
sargramostim
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00257322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257322.